Finding the right aspirin dose to prevent Lynch cancer
Treatments studied
Part of Cancer, Digestive system, Genetic & congenital clinical trials.
This study tests different aspirin doses to see which works best to help prevent cancers in people with Lynch syndrome. If you have Lynch syndrome, the trial may help lower your future cancer risk with the correct dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have confirmed Lynch syndrome from a specific gene change (MLH1, MSH2, MSH6, PMS2, or related EPCAM change)
- You can swallow tablets
- You can sign consent to take part voluntarily
- You are not already taking anti-inflammatory medicines regularly (more than 3 doses per week), unless your current use can be switched to what the study provides
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system interacts with the gut lining in people with Lynch syndrome and those without. It may help us better understand how Lynch syndrome affects the body.
This trial tests whether daily aspirin or naproxen can “intercept” (stop) cancer from starting or coming back in people with Lynch syndrome who are currently cancer-free. Participants are randomly assigned to one of the two drugs, and neither the participant nor the team knows which one you’re taking.
This trial tests whether mesalamine, a medicine used for bowel inflammation, can help prevent colorectal cancer in people with Lynch syndrome who do not currently have cancer. It may help by lowering the chance that new pre-cancer growths form over time.
This study tests a special CAD-EYE system to help detect abnormal (potentially cancer-related) growths during colonoscopy in people with Lynch syndrome. It may improve how reliably clinicians find lesions early, when treatment can be easier.
This study checks tumor tissue from colorectal cancer surgery for signs of Lynch syndrome, a genetic condition that increases cancer risk. If found, you can get genetic counseling to help you and your family.
This trial tests whether a personalized vaccine made from your own immune cells can help prevent cancer in people with Lynch syndrome. You must have no history of cancer and be willing to have regular colonoscopies.
Hear when a new Lynch Syndrome I (Site-specific Colonic Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.